Skip to main content
New Microbes and New Infections logoLink to New Microbes and New Infections
. 2024 Apr 14;59:101412. doi: 10.1016/j.nmni.2024.101412

Zoonotic transmission of Chlamydia felis from domestic cats; A case series of chronic follicular conjunctivitis in humans

Laura Hughes a,⁎,1, Stijn Visser b,1, Edou Heddema c, Nicole de Smet d, Tim Linssen e, Robert Jan Wijdh b, Robert Huis in ’t Veld a
PMCID: PMC11040131  PMID: 38660577

Abstract

We present three cases of chronic follicular conjunctivitis resulting from the zoonotic transmission of Chlamydia felis from domestic cats. Our objective is to raise awareness regarding the potential zoonotic transmission of Chlamydia felis from domestic cats and describe the methodology for definitive pathogen identification using Polymerase Chain Reaction (PCR) and subsequent sequence analysis, a useful tool in the identification of these rare pathogens. We discuss the factors that could be contributing to the potential under-diagnosis of zoonotic C. felis infections and propose a treatment regime for cases of C. felis-related conjunctivitis.

Keywords: Chlamydia felis, zoonosis; Follicular conjunctivitis; Sequence analysis

1. Introduction

Chlamydia felis is an important cause of conjunctivitis, and sometimes respiratory tract infections, in domestic cats (Felis catus) [1,2]. It is a Gram-negative obligate intracellular bacterium and therefore cannot be cultured using standard media. As such, diagnosis of Chlamydiae relies on the use of molecular diagnostic tools including Polymerase Chain Reaction (PCR) [3].

In cats, C. felis infections are most common in young animals (less than one year old). Infected cats can shed C. felis in ocular and respiratory tract secretions and rectally for up to two months, during which time most domestic cats will show signs of conjunctivitis and/or rhinitis [4]. However, it is known that some cats remain persistently asymptomatically infected and shed C. felis for longer periods of time [5], posing a potential zoonotic risk. Transmission between cats occurs through direct, close contact because C. felis does not survive well in the environment. As such, cats kept in groups (e.g., shelters) are more susceptible to infection [4].

Most cases of chlamydial conjunctivitis in humans are caused by Chlamydia trachomatis. Less frequently, other Chlamydial species have been found to be the cause of conjunctivitis including Chlamydia psittaci, Chlamydia pneumoniae and C. felis [6]. To date, there are 6 cases of C. felis associated follicular conjunctivitis in humans documented in the literature, the first case being documented by Ostler et al. in 1969 [7]. Three of the case reports were in immunocompetent patients, one case was in a patient with Human Immunodeficiency Virus (HIV) and the immune status of the two other patients was not reported [3,[7], [8], [9], [10]].

Here we report three cases of follicular conjunctivitis in patients infected via zoonotic transmission from domestic cats and describe how the definitive identification of the pathogen was made by Polymerase Chain Reaction (PCR) and subsequent sequence analysis, a useful tool in the identification of these rare pathogens. We propose a treatment regime for cases of C. felis-related conjunctivitis.

2. Case report one

A 38-year-old female was referred to the ophthalmology out-patient clinic of a tertiary referral center in the Netherlands with a 3-month history of red, painful eyes. The patient reported severe irritation of both eyes, for which she had already received a single 1 goral dose of azithromycin, local tobramycin, dexamethasone and fluorometholone eye drops (corticosteroid) without success. During the 3-month period, the patient had been tested for Chlamydial infection by the referring ophthalmologist, each time with a negative result. The patient had no significant past medical history and reported no previous eye infections. The patient had intraocular lenses (Artiflex) and therefore did not wear contact lenses. None of the patient's family members, with whom she shared a household, reported any eye symptoms.

The patient reported that her cat had sneezed into her face prior to the onset of her symptoms.

Ophthalmological examination of the patient revealed a reduced visual acuity of 20/50 (0,4) in the left eye and a normal visual acuity of 20/16 (1,2) in the right eye. In the right eye a mild papillary conjunctivitis of the nasal inferior tarsus and a marked papillary conjunctivitis of the superior tarsus was observed. Substantial papillary and follicular conjunctivitis of the inferior tarsus and a substantial giant papillary conjunctivitis of the superior tarsus of the left eye was present. The cornea of the left eye was unaffected however the cornea of the right eye showed a slightly irregular epithelium.

Conjunctival swabs for bacterial culture grew commensal skin flora. A Gram stain revealed no leucocytes, bacteria, fungi, or yeasts. The patient's serum was tested for antibodies against Chlamydia species (Chlamydia serology is not specific and shows cross-reactivity with several species) using an enzyme-linked immunosorbent assay (Serion ELISA classic, Virion\Serion, Würzburg, Germany). The patient tested positive for Chlamydia spp. IgA and IgG, which was suggestive of a recent infection.

PCRs for bacterial and viral pathogens were performed on conjunctival swabs from the patient including a PCR for Chlamydia psittaci (cross-reactive with C. felis) due to the patient's history of a cat sneezing in her face.

A conjunctival swab from the patient was placed in Universal Transport Medium (UTM) (Copan Diagnostics Inc., California, United States of America). DNA isolation and real-time PCR for Chlamydia pneumonia and Chlamydia psittaci was performed on a 250 μL aliquot using the b-CAP real-time PCR assay (gene target: outer membrane protein A gene, ompA) according to the protocol described by the manufacturer (Biolegio, Veldhoven, The Netherlands) on a BD-MAX system (BD Molecular Diagnostics, New Jersey, United States of America).

The conjunctival swab from the patient tested positive for C. psittaci with a CT-value of 39.

The sample was then sent to the Department of Medical Microbiology of the Zuyderland Medical Center (ZMC) –the Dutch National Reference Center for zoonotic Chlamydia species infections, for subsequent confirmation and species determination of the Chlamydial strain.

A diagnostic real-time PCR directed at the conserved domain of the Major Outer membrane protein gene was performed. This PCR can also detect C. abortus, C. felis and C. caviae, although there are mismatches in the primers for C. felis [11].

The Chlamydia species real-time PCR amplifies a 98 base pair (bp) segment of the 23s rRNA gene using primer Chlamydia 23s forward (5′- GAA AAG AAC CCT TGT TAA GGG AG -3′) and primer Chlamydia 23s reverse (5′- ACC TCG CCG TTT ARC TTA ACT CC -3′) as previously described [12,13].

Sanger Sequence analysis was performed by big-dye terminator technology (Baseclear, Leiden).

Sequence analysis of the PCR product identified the isolate as C. felis. A phylogenetic tree of the partial 23s rRNA gene sequences from the Chlamydia felis isolates described in this case series compared with reference sequences derived from Genbank was determined using P-distance (Fig. 1). Nucleotide sequences were aligned (98 bp) and analyzed using MegaXv11 software.

Fig. 1.

Fig. 1

Phylogenetic tree of partial 23s rRNA gene sequences from Chlamydia felis isolates described in this case series compared with reference sequences derived from Genbank determined using P-distance. Nucleotide sequences were aligned (98 bp) and analyzed using MegaXv11 software. ● Samples related to this case series.

The patient was treated with doxycycline 100 mg twice a day for 28 days. After 28 days, the patient was reassessed. The patient's visual acuity had returned to the normal baseline of the patient and there was no evidence of follicular conjunctivitis. The patient's cat also tested positive for C. felis using the Chlamydia spp. PCR followed by sequence analysis.

3. Case report 2

A 34-year-old female consulted her general practitioner with a 10 day history of conjunctivitis of the left eye, with eyelid swelling and purulent ocular discharge. The patient reported no pain and no change to her visual acuity. She was empirically treated with chloramphenicol eye drops 4 mg/mL 3–4 drops per day for two weeks to no good effect. During the follow up visit, the patient complained of pain in her left eye. Ophthalmological examination revealed mild erythema of the sclera of the left eye, swelling of the superior tarsus and marked epiphora. Fluorescein staining of the eye showed no abnormalities of the cornea. Because of the lack of treatment response, infection with Chlamydia trachomatis was considered as a differential diagnosis. Conjunctival swabs were taken for PCR and the patient was prescribed a single oral dose of 1 g azithromycin and topical tetracycline eye ointment (10 mg/g) for two weeks. This treatment led to a marked improvement and full recovery within two weeks.

The conjunctival swabs were submitted to the Zuyderland Medical Center for a Chlamydia trachomatis PCR, but by mistake a Chlamydia spp. real-time PCR was requested instead of a Chlamydia trachomatis PCR (both tests are available at the ZMC). The Chlamydia spp. PCR, which can detect all currently known species, was positive and consecutive partial sequence analysis of the 23s gene (as described in case report 1) revealed the species to be Chlamydia felis (Fig. 1). On questioning it appeared that the patient owned 4 cats that had recently been treated for conjunctivitis by a veterinarian. Attempts to test her cats for C. felis were unsuccessful.

4. Case report 3

A 31-year-old female was referred to an ophthalmology out-patient clinic by her general practitioner with a 2-week history of a red left eye with a feeling of a foreign particle under the eyelid. Her past medical history was unremarkable. Under the assumption of an episcleritis, her general practitioner had treated her with prednisolone and chloramphenicol eyedrops. Ophthalmological examination of the patient revealed a slightly reduced visual acuity of 0.9 in the left eye and a normal visual acuity in the right eye. Hyperaemia and papillary and follicular conjunctivitis of the left eye were observed. The patient was prescribed Trafloxal eyedrops (ofloxacin 3 mg/mL) four times a day and ointment at night. Conjunctival swabs were taken for Chlamydia trachomatis PCR. Bacterial culture was not requested. By mistake, a Chlamydia spp. and C. psittaci multiplex real-time PCR was requested and gave a positive result (C. psittaci: Ct-value 36.5; Chlamydia spp.: Ct-value 32.5). Additional sequence analysis of the PCR product (as described in case report 1) identified the isolate as C. felis (Fig. 1). Based on this result antibiotic treatment was switched to doxycycline 100 mg once daily for 14 days with a loading dose of 200 mg on the first day of treatment. In addition, azithromycin eyedrops twice a day for three days were prescribed. Before symptom onset, the patient had cared for parrots owned by her parents for 2 weeks. As species determination was still ongoing, public health officials tested the birds for C. psittaci by PCR but they tested negative.

After 28 days the patient was reassessed. The patient had no further symptoms and her follicular conjunctivitis had resolved. Chlamydia spp. PCR's on conjunctival swabs from both eyes were negative at this time.

The patient reported that she had a cat, which had been sick with episodes of vomiting 6 weeks prior to the patient developing follicular conjunctivitis. Meanwhile she had managed to take a swab sample from early morning eye discharge from the cat. This was tested and found to be positive in the Chlamydia spp. PCR. Sequence analysis was performed as described in case report 1 and revealed the species to be C. felis (Fig. 1). At the time of testing the cat had no symptoms. The cat was seen by a veterinarian for the C. felis infection but a decision was made not to treat due to the cat being an asymptomatic carrier.

5. Discussion

Here we describe three cases of C. felis-associated papillary conjunctivitis over a period of 6 years from 2017 until 2022. C. felis is considered a rare cause of papillary conjunctivitis in humans, with only 6 cases reported in the literature over a period of 48 years prior to the three cases that we report here [3,[7], [8], [9], [10]]. Two from the three cases that we report here were detected by “mistake” when samples were screened for Chlamydia spp. with a Chlamydia spp. real-time PCR or tested for C. pneumonia and C. psittaci using the b-CAP RT-PCR assay, which gave a positive signal for C. psittaci. C. felis is known to be closely related to C. psittaci [14]. The reverse primer for C. psittaci in the b-CAP RT-PCR assay has only two mismatches compared with C. felis explaining why the C. felis isolates from two cases gave a positive result for C. psittaci, albeit at higher Ct-values.

There are no diagnostic microbiology laboratories in the Netherlands that have a specific diagnostic test for C. felis. In the three cases that we report, C. felis was detected due to a positive result for C. psittaci or Chlamydia spp. in a multiplex real-time PCR. Sequence analysis was then performed on the PCR product from case one because the clinical microbiologist suspected C. felis infection after ascertaining that the patient had a history of exposure to cats. In cases 2 and 3, only the final identification of C. felis pointed towards patient's cats as the source of infection. It is therefore important to raise awareness among ophthalmologists, general practitioners and clinical microbiologists that C. felis should be considered in the differential diagnosis in cases of follicular conjunctivitis with a history of exposure to cats. This should be confirmed with a positive PCR for C. psittaci (cross-reacting with C. felis) or Chlamydia spp., followed by subsequent targeted sequencing, or a specific C. felis PCR as described by Wons et al. [3].

The prevalence of C. felis in domestic cats in the Netherlands is unknown. A recent survey in Switzerland of 309 stray cats and 86 pet cats revealed a C. felis prevalence of 18.1 % and 11.6 % in stray and pet cats respectively [15]. In 2019 a similar cross-sectional survey of 57 stray/shelter cats and 83 pet cats in Slovakia revealed a C. felis prevalence of 33.3 % in stray/shelter cats and 10 % in pet cats that were allowed to go outside regularly [16]. In both surveys, significantly higher rates of C. felis infection were found in cats displaying signs of conjunctivitis but there were also asymptomatic carriers identified [15,16] and a study of C. felis in cats in Italy also revealed a prevalence of 3 % in asymptomatic healthy cats [17].

Vaccines against C. felis for use in domestic cats are available but C. felis is not included in the “standard” cat vaccination scheme in the Netherlands, which includes vaccines against feline panleukopenia virus, feline calcivirus and feline herpes virus. Furthermore, feline Chlamydial vaccines do not provide complete protection [4]. Therefore the number of cats vaccinated against C. felis in the Netherlands is likely to be low.

There are no treatment guidelines for C. felis-associated follicular conjunctivitis. The current first choice antibiotic treatment for C. trachomatis-associated conjunctivitis in the Netherlands is a single 1 g oral dose of azithromycin [18]. Of the three patients described here, two patients were treated with this antibiotic regimen (case 1 and case 2). In case 1, the treatment was given initially by the referring ophthalmologist however it was clinically unsuccessful. In case 2, treatment with azithromycin appeared to be clinically successful however, azithromycin was given in combination with tetracycline eye ointment after the patient had been treated with chloramphenicol eye drops for two weeks. Treatment failure up to 17 % with this antibiotic regimen has been reported for several infections caused by C. trachomatis, especially in rectal infections [[19], [20], [21], [22], [23]] and the treatment of trachoma in young children. Azithromycin is no longer the first-choice antibiotic for these infections, instead 100 mg doxycycline orally twice a day for between 7 and 21 days is recommended and has been shown to be more effective [24]. Therefore, a patient presenting with chronic conjunctivitis who has recently been treated with 1 g azithromycin should be evaluated carefully before ruling out chlamydial infection. In two of the three cases described (1 and 3), oral doxycycline was part of the treatment regime that resulted in the successful treatment of C. felis-associated follicular conjunctivitis. The dose of doxycycline used in case 1 was 100 mg twice a day for 28 days and a shorter course was used in case 3 of 100 mg once a day for 14 days with a loading dose of 100 mg twice a day on the first day. A prolonged course of doxycycline was also required to eradicate infection in two cases of C. felis associated follicular conjunctivitis described by Hartley et al. [10] and Wons et al. [3] This would suggest that a longer course of doxycycline (a loading dose followed by 14–28 days) should be considered as a treatment regime in cases of C. felis associated conjunctivitis.

In conclusion, in cases of chronic follicular conjunctivitis, patients should be questioned about exposure to cats and C. felis should be considered in the differential diagnosis and confirmed with a positive PCR for C. psittaci or Chlamydia spp., and subsequent targeted sequencing or, if available, specific C. felis PCR.

Ethics statement

Informed consent was obtained from all patients.

Funding

Species determination by sequence analysis was financially supported by a grant from the RIVM, the Dutch National Institute for Public Health and the Environment.

CRediT authorship contribution statement

Laura Hughes: Writing – original draft, Visualization, Investigation, Formal analysis, Data curation. Stijn Visser: Writing – original draft, Visualization, Investigation, Formal analysis. Edou Heddema: Writing – review & editing, Methodology, Formal analysis, Data curation. Nicole de Smet: Writing – review & editing, Formal analysis, Data curation. Tim Linssen: Writing – review & editing, Formal analysis, Data curation. Robert Jan Wijdh: Writing – review & editing, Supervision, Investigation, Conceptualization. Robert Huis in ’t Veld: Writing – review & editing, Supervision, Methodology, Investigation, Conceptualization.

Declaration of competing interest

All authors declare that they have no conflicts of interest.

Handling Editor: Patricia Schlagenhauf

References

  • 1.Sykes J.E., Anderson G.A., Studdert V.P., Browning G.F. Prevalence of feline Chlamydia psittaci and feline herpesvirus 1 in cats with upper respiratory tract disease as determined by duplex polymerase chain reaction. J Vet Intern Med. 1999;13:153–162. doi: 10.1892/0891-6640(1999)013<0153:pofpaf>2.3.co;2. [DOI] [PubMed] [Google Scholar]
  • 2.Walter J., Foley P., Yason C., Vanderstichel R., Muckle A. Prevalence of feline herpesvirus-1, feline calcivirus, Chlamydia felis, and Bordetella bronchiseptica in a population of shelter cats on Prince Edward Island. Can J Vet Res. 2020;84(3):181–188. [PMC free article] [PubMed] [Google Scholar]
  • 3.Wons J., Meiller R., Bergua A., Bogdan C., Geißdörfer W. Follicular conjunctivitis due to Chlamydia felis – case report, review of the literature and improved molecular diagnostics. Front Med. 2017;4:105. doi: 10.3389/fmed.2017.00105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Polkinghorne A. Chlamydial conjunctivitis in animals. MSD veterinary manual. 2020. https://www.msdvetmanual.com/eye-diseases-and-disorders/chlamydial-conjunctivitis/chlamydial-conjunctivitis-in-animals?query=chlamydia%20felis last accessed: 16th December 2023.
  • 5.Borel N., Polkinghorne A., Pospischil A. A review on chlamydial Diseases in animals: still a challenge for pathologists? Vet Pathol. 2018;55:374–390. doi: 10.1177/0300985817751218. [DOI] [PubMed] [Google Scholar]
  • 6.Schachter J., Chernesky M. Chlamydia. In: Manual of clinical microbiology. 12th. Carroll K.C., Pfaller M.A., Landry M.L., McAdam A.J., Patel R., Richer S.S., Warnock D.W., editors. ASM Press; Washington, DC: 2019. pp. 1137–1148. [Google Scholar]
  • 7.Ostler H.B., Schachter J., Dawson C.R. Acute follicular conjunctivitis of epizootic origin. Feline pneumonitis. Arch Ophthalmol. 1969;82:587–591. doi: 10.1001/archopht.1969.00990020587003. [DOI] [PubMed] [Google Scholar]
  • 8.Darougar S., John A.C., Viswalingam M., Cornell L., Jones B.R. Isolation of Chlamydia psittaci from a patient with interstitial keratitis and uveitis associated with otological and cardiovascular lesions. Br J Ophthalmol. 1978;62:709–714. doi: 10.1136/bjo.62.10.709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Lietman T., Brooks D., Moncada J., Schachter J., Dawson C., Dean D. Chronic follicular conjunctivitis associated with Chlamydia psittaci or Chlamydia pneumoniae. Clin Infect Dis. 1998;26:1335–1340. doi: 10.1086/516373. [DOI] [PubMed] [Google Scholar]
  • 10.Hartley J.C., Stevenson S., Robinson A.J., et al. Conjunctivitis due to Chlamydia felis (Chlamydia psittaci feline pneumonitis agent) acquired from a cat: case report with molecular characterization of isolates from the patient and cat. J Infect. 2001;43:7–11. doi: 10.1053/jinf.2001.0845. [DOI] [PubMed] [Google Scholar]
  • 11.Heddema E.R., Beld M.G., de Wever B., Langerak A.A., Pannekoek Y., Duim B. Development of an internally controlled real-time PCR assay for detection of Chlamydophila psittaci in the LightCycler 2.0 system. Clin Microbiol Infect. 2006;12(6):571–575. doi: 10.1111/j.1469-0691.2006.01417.x. [DOI] [PubMed] [Google Scholar]
  • 12.Ehricht R., Slickers P., Goellner S., Hotzel H., Sachse K. Optimized DNA microarray assay allows detection and genotyping of single PCR-amplifiable target copies. Mol Cell Probes. 2006;20(1):60–63. doi: 10.1016/j.mcp.2005.09.003. [DOI] [PubMed] [Google Scholar]
  • 13.Everett K.D., Bush R.M., Andersen A.A. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol. 1999;49(2):415–440. doi: 10.1099/00207713-49-2-415. [DOI] [PubMed] [Google Scholar]
  • 14.Sachse K., Bavoil P.M., Kaltenboeck B., et al. Emendation of the family Chlamydiaceae: proposal of a single genus, Chlamydia, to include all currently recognized species. Syst Appl Microbiol. 2015;38(2):99–103. doi: 10.1016/j.syapm.2014.12.004. [DOI] [PubMed] [Google Scholar]
  • 15.Bressan M., Rampazzo A., Kuratli J., Marti H., Pesch T., Borel N. Occurrence of Chlamydiacea and Chlamydia felis pmp9 typing in conjunctival and rectal samples of Swiss stray and pet cats. Pathogens. 2021;10(8):951. doi: 10.3390/pathogens10080951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Halánová M., Petrová L., Halán M., Trbolová A., Babinská I., Weissová T. Impact of way of life and environment on the prevalence of Chlamydia felis in cats as potentional sources of infection for humans. Ann Agric Environ Med. 2019;26(2):222–226. doi: 10.26444/aaem/100655. [DOI] [PubMed] [Google Scholar]
  • 17.Di Francesco A., Piva S., Baldelli R. Prevalence of Chlamydophila felis by PCR among healthy pet cats in Italy. New Microbiol. 2004;27:199–201. [PubMed] [Google Scholar]
  • 18.Nederlandse Vereniging voor Dermatologie en Venereologie (NVDV) Seksueel overdraagbare aandoeningen multidisciplinaire richtlijn 2018. 2019. https://www.soaaids.nl/files/2020-01/mdr-multidisciplinaire-richtlijn-soa-2018-update-2019-versie-oktober-2019.pdf (last accessed 16th December 2023.
  • 19.Gratrix J., Brandley J., Dane M., et al. A retrospective review of treatment failures using azithromycin and doxycycline in the treatment of rectal chlamydia infections in women and men who have sex with men. Sex Transm Dis. 2016;43:110–112. doi: 10.1097/OLQ.0000000000000403. [DOI] [PubMed] [Google Scholar]
  • 20.Chen L.F., Wang T.C., Chen F.L., et al. Efficacy of doxycycline versus azithromycin for the treatment of rectal chlamydia: a systematic review and meta-analysis. J Antimicrob Chemother. 2021;76:3103–3110. doi: 10.1093/jac/dkab335. [DOI] [PubMed] [Google Scholar]
  • 21.Dombrowski J.C., Wierzbicki M.R., Newman L.M., et al. Doxycycline versus azithromycin for the treatment of rectal chlamydia in men who have sex with men: a randomized controlled trial. Clin Infect Dis. 2021;73:824–831. doi: 10.1093/cid/ciab153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Lau A., Kong F.Y.S., Fairley C.K., et al. Azithromycin or doxycycline for asymptomatic rectal chlamydia trachomatis. N Engl J Med. 2021;384:2418–2427. doi: 10.1056/NEJMoa2031631. [DOI] [PubMed] [Google Scholar]
  • 23.Kang-Birken S.L. Challenges in treating Chlamydia trachomatis, including rectal infections: is it time to go back to doxycycline? Ann Pharmacother. 2022;56:330–338. doi: 10.1177/10600280211029945. [DOI] [PubMed] [Google Scholar]
  • 24.Ab E., Bruggeling N.M., Donker G.A., et al. NHG (nederlands huisartsen genootschap)-standaard: het soa-consult (M82) 2022. https://richtlijnen.nhg.org/files/pdf/70_Het%20soa-consult_september-2022.pdf (last accessed: 16th December 2023)

Articles from New Microbes and New Infections are provided here courtesy of Elsevier

RESOURCES